Phase 2 Dyslipidaemia Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2Phase 3
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
Dyslipidaemia
AstraZeneca360 enrolled43 locationsNCT06834932
Recruiting
Phase 2
A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia
Dyslipidaemia
AstraZeneca76 enrolled9 locationsNCT07218900
Completed
Phase 2
Investigating the effect of a soluble seaweed dietary fibre on gut, metabolic and skin health.
Keratoderma/psoriatic skin conditionIncreased Chronic InflammationImpaired Glucose Tolerance and Insulin resistance+2 more
University of Wollongong80 enrolled1 locationACTRN12617001010381
Completed
Phase 2
Dyslipidaemia, Oxidative Stress And Arterial Wall Function In Non-Insulin Dependent Diabetes
Type 2 DiabetesDyslipidaemia
Professor Gerald F Watts80 enrolled1 locationACTRN12611001150932